Cargando…
Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy
BACKGROUND/AIMS: To determine the prognostic value of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 in gallbladder cancer (GBC) during palliative chemotherapy. METHODS: One hundred and twenty-three patients with pathologically confirmed unresectable GBC were included. Differences...
Autores principales: | Lee, Jae Woo, Kim, Yong-Tae, Lee, Sang Hyub, Son, Jun Hyuk, Kang, Jin Woo, Ryu, Ji Kon, Jang, Dong Kee, Paik, Woo Hyun, Lee, Ban Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753691/ https://www.ncbi.nlm.nih.gov/pubmed/29069888 http://dx.doi.org/10.5009/gnl16588 |
Ejemplares similares
-
Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
por: You, Min su, et al.
Publicado: (2019) -
Step-wise endoscopic approach to palliative bilateral biliary drainage for unresectable advanced malignant hilar obstruction
por: Choi, Jin Ho, et al.
Publicado: (2019) -
A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer
por: Woo, Sang Myung, et al.
Publicado: (2013) -
Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy
por: Chung, Kwang Hyun, et al.
Publicado: (2017) -
Innovation of EUS-guided transmural gallbladder drainage using a novel self-expanding metal stent
por: Huh, Gunn, et al.
Publicado: (2020)